ZA974546B - Medicinal aerosol formulations of formoterol - Google Patents

Medicinal aerosol formulations of formoterol

Info

Publication number
ZA974546B
ZA974546B ZA974546A ZA974546A ZA974546B ZA 974546 B ZA974546 B ZA 974546B ZA 974546 A ZA974546 A ZA 974546A ZA 974546 A ZA974546 A ZA 974546A ZA 974546 B ZA974546 B ZA 974546B
Authority
ZA
South Africa
Prior art keywords
formoterol
aerosol formulations
medicinal aerosol
medicinal
formulations
Prior art date
Application number
ZA974546A
Other languages
English (en)
Inventor
Martin James Oliver
Simon Gordon Paling
Philip Anthony Jinks
Sukhbinder Kaur Jaiswal
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795182&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA974546(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of ZA974546B publication Critical patent/ZA974546B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA974546A 1996-06-11 1997-05-23 Medicinal aerosol formulations of formoterol ZA974546B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612297.3A GB9612297D0 (en) 1996-06-11 1996-06-11 Medicinal aerosol formulations

Publications (1)

Publication Number Publication Date
ZA974546B true ZA974546B (en) 1998-11-23

Family

ID=10795182

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA974546A ZA974546B (en) 1996-06-11 1997-05-23 Medicinal aerosol formulations of formoterol

Country Status (16)

Country Link
EP (2) EP1400239A1 (cg-RX-API-DMAC10.html)
JP (1) JP5000793B2 (cg-RX-API-DMAC10.html)
AR (1) AR009231A1 (cg-RX-API-DMAC10.html)
AT (1) ATE275940T1 (cg-RX-API-DMAC10.html)
AU (1) AU726382B2 (cg-RX-API-DMAC10.html)
CA (1) CA2257841C (cg-RX-API-DMAC10.html)
DE (1) DE69730723T2 (cg-RX-API-DMAC10.html)
DK (1) DK0934057T3 (cg-RX-API-DMAC10.html)
ES (1) ES2229366T3 (cg-RX-API-DMAC10.html)
GB (1) GB9612297D0 (cg-RX-API-DMAC10.html)
ID (1) ID19520A (cg-RX-API-DMAC10.html)
NO (1) NO320403B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ333202A (cg-RX-API-DMAC10.html)
PT (1) PT934057E (cg-RX-API-DMAC10.html)
WO (1) WO1997047286A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA974546B (cg-RX-API-DMAC10.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
EP1121112B1 (de) * 1998-10-17 2002-06-05 Boehringer Ingelheim Pharma KG Lagerfähiges wirkstoffkonzentrat mit formoterol
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
UA73986C2 (uk) 2000-05-22 2005-10-17 К'Єзі Фармачеутічі С.П.А. АЕРОЗОЛЬНА КОМПОЗИЦІЯ, ЩО МІСТИТЬ <font face="Symbol">b</font>2-АДРЕНЕРГІЧНИЙ АГОНІСТ ТРИВАЛОЇ ДІЇ, ДОЗУЮЧИЙ ІНГАЛЯТОР ПІД ТИСКОМ ТА СПОСІБ ЙОГО ЗАПОВНЕННЯ
SE0004750D0 (sv) * 2000-12-19 2000-12-19 Astrazeneca Ab Novel formulation
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
WO2004020289A1 (en) 2002-08-27 2004-03-11 Schering Corporation Process for producing metered dose inhaler formulations
EP1635845A1 (en) * 2003-06-13 2006-03-22 ALTANA Pharma AG Formoterol and ciclesonide combination
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
CA2542530A1 (en) * 2003-10-20 2005-05-12 Schering Corporation Pharmaceutical aerosol compositions
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
ES2398480T3 (es) * 2006-10-17 2013-03-19 Lithera, Inc. Procedimientos, composiciones, y formulaciones para el tratamiento de la enfermedad ocular tiroidea
PL2435024T3 (pl) * 2009-05-29 2017-01-31 Pearl Therapeutics, Inc. Dostarczanie substancji czynnych do dróg oddechowych oraz powiązane sposoby i systemy
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
DK2727582T3 (en) * 2009-10-02 2016-05-17 Chiesi Farma Spa Pharmaceutical aerosol formulations of formoterol and beclomethasone dipropionate
CA2905542C (en) 2013-03-15 2022-05-03 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05508616A (ja) * 1989-02-23 1993-12-02 ローヌー　プーラン　ローラー　インターナショナル（ホウルディングス）インコーポレイテッド 治療用エアロゾル剤
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
SK140493A3 (en) * 1991-06-10 1994-10-05 Schering Corp Non-chlorofluorocarbon aerosol formulations
YU59192A (sh) * 1991-06-10 1994-12-28 Schering Corporation Formulacija aerosola koje ne sadrže hlorofluorougljenična jedinjenja
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
ATE128350T1 (de) * 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
EP1086688B1 (en) * 1991-12-18 2004-03-03 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
GB9207400D0 (en) * 1992-04-02 1992-05-13 Smithkline Beecham Plc Novel use
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
NO985720D0 (no) 1998-12-07
NO985720L (no) 1999-02-11
CA2257841A1 (en) 1997-12-18
EP1400239A1 (en) 2004-03-24
AR009231A1 (es) 2000-04-12
ID19520A (id) 1998-07-16
ATE275940T1 (de) 2004-10-15
JP2000513340A (ja) 2000-10-10
NZ333202A (en) 2000-06-23
CA2257841C (en) 2008-05-20
DE69730723T2 (de) 2005-10-06
DE69730723D1 (de) 2004-10-21
EP0934057B1 (en) 2004-09-15
JP5000793B2 (ja) 2012-08-15
AU3373997A (en) 1998-01-07
EP0934057A1 (en) 1999-08-11
NO320403B1 (no) 2005-11-28
ES2229366T3 (es) 2005-04-16
WO1997047286A1 (en) 1997-12-18
DK0934057T3 (da) 2005-01-24
AU726382B2 (en) 2000-11-02
GB9612297D0 (en) 1996-08-14
PT934057E (pt) 2004-12-31

Similar Documents

Publication Publication Date Title
ZA974546B (en) Medicinal aerosol formulations of formoterol
HUP0000795A3 (en) Medicinal aerosol formulations comprising budesonide
IL116460A0 (en) Aerosol drug formulations
ZA975883B (en) High dose liposomal aerosol formulations
AP9500733A0 (en) Pharmaceutical formulations
GB9404248D0 (en) Pharmaceutical formulations
HUP0200066A3 (en) Pharmaceutical aerosol formulations containing fluoroalkanes and budesonide
IL128714A (en) Chlorofluorocarbon-free mometasone furoate aerosol formulations
EG21177A (en) Insecticidal aerosol composition and insecticidal composition for preparation of same
IL112897A0 (en) Aerosol drug formulations containing vitamin e
AU1847695A (en) Pharmaceutical formulations of cntf
GB9304745D0 (en) Use of pharmaceutical formulations
HK1021701A (en) Medicinal aerosol formulations comprising budesonide
GB9413542D0 (en) Pharmaceutical formulations
ZA9510754B (en) Aerosol drug formulations
ZA976038B (en) Medicinal aerosol solution formulation
HK1003618A (en) Aerosol drug formulations
ZA956970B (en) Improved pharmaceutical formulations their preparation and use
ZA953239B (en) Pharmaceutical formulations
GB9408164D0 (en) Pharmaceutical formulations
GB9408151D0 (en) Pharmaceutical formulations
GB9426113D0 (en) Pharmaceutical formulations
GB9417953D0 (en) Pharmaceutical formulations
GB9414216D0 (en) Pharmaceutical formulations
GB9401738D0 (en) Pharmaceutical formulations